Videos

Richard D. Kim, MD, discusses the safety profile of the combination of atezolizumab and bevacizumab in hepatocellular carcinoma.  



Dr. Kim on the Safety Profile of Atezolizumab/Bevacizumab in HCC 

Heather ​S. Han, MD, discusses the benefit of adding pertuzumab to trastuzumab and chemotherapy in the phase 3 APHINITY trial in patients with HER2-positive early-stage breast cancer.

Dr. Han on the APHINITY Trial in HER2+ Early-Stage Breast Cancer

Rutika J. Mehta, MD, MPH, discusses the ​current treatment paradigm in HER2-positive gastric cancer. 

Dr. Mehta on the Current Treatment Paradigm in HER2-Positive Gastric Cancer 

Kamran A. Ahmed, MD, discusses the impact of neratinib on patients with central nervous system metastases and HER2-positive breast cancer.  



Dr. Ahmed on the Impact of Neratinib on CNS Metastases in HER2+ Breast Cancer 

Articles

Jonathan Strosberg, MD, highlights key trials spanning gastrointestinal cancers, challenges faced in certain diseases, and the focus of future research efforts. 

Strosberg Shares Key Strategies Propelling Progress in Gastrointestinal Cancers

Hatem Soliman, MD, discusses the utility of antibody-drug conjugates in breast cancer.  



Moffitt

Latest from Moffitt

New content coming soon, please check back later.